With a rich professional history in financial consulting and strategic operations, Tabitha Granzow has emerged as a significant contributor to investment leadership. She is recognized for her ability to identify transformative opportunities within various industries, emphasizing sustainable growth and organizational efficiency. Her experience spans both the public and private sectors, allowing her to navigate complex market dynamics effectively. In addition, she leverages robust analytical skills developed through extensive education in finance and economics to drive performance-enhancing initiatives. As an advocate for innovation in business processes, Granzow remains at the forefront of fostering adaptive strategies that align with emerging market trends.
With a rich professional history in financial consulting and strategic operations, Tabitha Granzow has emerged as a significant contributor to investment leadership. She is recognized for her ability to identify transformative opportunities within various industries, emphasizing sustainable growth and organizational efficiency. Her experience spans both the public and private sectors, allowing her to navigate complex market dynamics effectively. In addition, she leverages robust analytical skills developed through extensive education in finance and economics to drive performance-enhancing initiatives. As an advocate for innovation in business processes, Granzow remains at the forefront of fostering adaptive strategies that align with emerging market trends.
Identifying opportunities amidst shifting market dynamics is a hallmark of Granzow's investment approach. Her focus lies in supporting innovative solutions that drive operational efficiencies, reflecting a keen understanding of the need for agility in today's fast-paced environment. By leveraging her extensive expertise across both public and private sectors, she aims to unlock value through strategic transformations that prioritize sustainable growth. This emphasis on adaptability not only defines her decision-making but also positions her as an advocate for evolving business practices aligned with contemporary trends.
Identifying opportunities amidst shifting market dynamics is a hallmark of Granzow's investment approach. Her focus lies in supporting innovative solutions that drive operational efficiencies, reflecting a keen understanding of the need for agility in today's fast-paced environment. By leveraging her extensive expertise across both public and private sectors, she aims to unlock value through strategic transformations that prioritize sustainable growth. This emphasis on adaptability not only defines her decision-making but also positions her as an advocate for evolving business practices aligned with contemporary trends.
| Trades 4894 | Longs Won 3233/4894 66% | Profit Factor 0.79 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $13.23M |
| Average Win $786,314.23 | Best Trade (Dec 30) $300.52M | Sharpe Ratio -7.2 |
| Average Loss -$1.94M | Worst Trade (Jun 29) -$405.29M | Z-Score -18.33 (100%) |
| Commissions $0 | Avg. Trade Length 1y 8m 1w 5d | Expectancy -$5,997.62 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 307 | 276 | 245 | 215 | 184 | 153 | 123 | 92 | 61 | 31 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 85,537 | $20.99M | $29.62M | - | $8.63M | 41.12% | -0.569% |
ABBV AbbVie Inc. | 44,079 | $8.7M | $12.62M | - | $3.92M | 45.04% | +0.358% |
ABT Abbott Laboratories | 18,491 | $2.29M | $1.91M | - | -$375,457.6 | -16.42% | +0.849% |
ADI Analog Devices, Inc. | 10,041 | $2.43M | $3.92M | - | $1.49M | 61.2% | +1.237% |
AFL Aflac Incorporated | 2,523 | $282,071.4 | $304,324.26 | - | $22,252.86 | 7.89% | -2.15% |
AGG iShares Core U.S. Aggregate Bond ETF | 17,304 | $1.75M | $1.66M | - | -$86,759.34 | -4.96% | -0.146% |
AMGN Amgen Inc. Common Stock | 9,548 | $3.08M | $4.21M | - | $1.13M | 36.71% | -1.355% |
AMZN Amazon.com Inc | 45,250 | $8.5M | $11.27M | - | $2.77M | 32.53% | -0.567% |
APD Air Products and Chemicals Inc. | 4,000 | $1.11M | $1.23M | - | $116,279.96 | 10.45% | -0.298% |
AVGO Broadcom Inc. | 17,884 | $3.31M | $5.81M | - | $2.5M | 75.47% | +0.445% |
BAC Bank of America Corporation | 87,389 | $3.5M | $4.43M | - | $925,058.4 | 26.41% | -0.812% |
BDJ BlackRock Enhanced Equity Dividend Trust | 14,696 | $127,120.4 | $139,391.56 | - | $12,271.16 | 9.65% | -0.888% |
BLK BlackRock, Inc. | 3,473 | $3.29M | $3.86M | - | $573,309.59 | 17.44% | -2.256% |
BMY Bristol-Myers Squibb Company | 28,488 | $1.51M | $1.75M | - | $247,042.18 | 16.39% | -2.27% |
BRK-A Berkshire Hathaway Inc. | 7 | $4.84M | $5.69M | - | $847,350.84 | 17.51% | -1.008% |
BRK-B Berkshire Hathaway Inc. | 14,961 | $6.89M | $8.1M | - | $1.21M | 17.64% | -1.007% |
CAH Cardinal Health, Inc. | 37,726 | $4.17M | $9.49M | - | $5.32M | 127.63% | -1.576% |
CASY Casey's General Stores, Inc. | 3,710 | $2.66M | $2.57M | - | -$86,802.18 | -3.26% | -2.852% |
CAT Caterpillar Inc. | 6,967 | $2.77M | $4.79M | - | $2.02M | 72.66% | -2.373% |
CATX Perspective Therapeutics Inc. | 19,061 | $254,464.35 | $31,545.95 | - | -$222,918.4 | -87.6% | -26.77% |